The Alpha Clinics Network is funded and supported by the California Institute for Regenerative Medicine (CIRM). The Network features nine world-class medical centers throughout California with a ...

Therapeutic Candidate or Device iPSC-derived CD19 CAR T cell therapy Indication Systemic Lupus Erythematosus Therapeutic Mechanism Depletion of CD19+ B cells and plasmablasts Unmet Medical Need ...

CIRM is supporting a network of 11 Shared Resources Laboratories (SRLs) for Stem Cell-Based Modeling, an important component of CIRM’s Infrastructure Program designed to address challenges that hinder ...

Each of these facilities will support accelerating and de-risking the path to commercialization for cell and gene therapies, advancing industry standards and quality by design, and building a diverse ...

CIRM applicants and awardees wishing to obtain more information about the CIRM Industry Resource Partners’ hPSC offerings should complete the form below to contact CIRM.

South San Francisco, CA, August 30, 2024 – The California Institute for Regenerative Medicine, one of the world’s largest institutes dedicated to regenerative medicine, approved $67.5 million to ...

FOR IMMEDIATE RELEASE Contact: Esteban Cortez Director, Marketing & Communications [email protected] South San Francisco, CA, January 30, 2025 – The California Institute for Regenerative Medicine ...

South San Francisco, CA, May 30, 2024 – The California Institute for Regenerative Medicine (CIRM), one of the world’s largest institutions dedicated to regenerative medicine, has awarded $53 million ...

South San Francisco, CA, March 29, 2024 – The California Institute for Regenerative Medicine (CIRM), one of the world’s largest institutions dedicated to regenerative medicine, has awarded to fund ...

South San Francisco, CA, November 21, 2024 – The California Institute for Regenerative Medicine (CIRM), one of the world’s largest institutions dedicated to regenerative medicine, has approved ...

Through the $4.7 million award, Aaron Nagiel, MD, PhD, and the team at Blue Gen Therapeutics Foundation will advance the development of a novel gene therapy for BCM, a rare, inherited eye disease that ...

South San Francisco, CA, Dec. 15, 2023 – The Independent Citizens Oversight Committee (ICOC), the governing board of the California Institute for Regenerative Medicine (CIRM), named Jonathan Thomas, ...